Inspiring headline doused by some cold reality…
But despite this anecdotal evidence, the only double-blind, placebo-controlled trial that investigated the effect of another GLP-1 analog in treating alcohol use disorder came to rather disappointing results. After they received a 2 mg dose of exenatide once a week for 26 weeks, patients with alcohol use disorder did not see a significant reduction in their heavy drinking days.
